Breaking News

Health records giant Epic faces a crossroads; FDA is pushing back on CBD-filled foods, drinks

 

Daily Recap

STAT+: Minimal compliance, or meaningful change? Epic faces a crossroads as new rules put pressure on health data sharing

By Casey Ross and Mohana Ravindranath

Molly Ferguson for STAT

STAT spoke with dozens of researchers, developers, and health system leaders about Epic’s outsize influence on health data sharing.

Read More

Coors, Mondelez, and other big food companies want to sell CBD-filled food and drinks. The FDA is staunchly opposed

By Nicholas Florko

Alex Hogan/STAT

The companies behind Coors Light, Oreos, and Ben & Jerry's want to start selling CBD-filled food and drinks. The FDA isn't having it.

Read More

STAT+: New CRISPR startup, drawing big-name backers, seeks to fix diseases caused by large DNA errors

By Allison DeAngelis

Adobe

The company, Tome Biosciences, is backed by Arch Venture Partners, Andreessen Horowitz, and the Longwood Fund.

Read More

A new study asks: Are we harming blood donors by taking blood from them?

By Brittany Trang

Justin Sullivan/Getty Images

The study investigating whether blood donors' low-iron status affected their quality of life or cognitive ability.

Read More

Opinion: Preventive services can improve Americans' health, but they are now on trial

By Anand Parekh

Adobe

A Texas judge's ruling could keep millions of Americans from getting the preventive services covered by the Affordable Care Act.

Read More

Poxviruses, outbreaks, and Ebola: A Q&A with a retiring CDC expert on bad bugs

By Helen Branswell

CDC

Inger Damon, one of the world's foremost poxvirus experts, stepped down from her post at the CDC at the end of August.

Read More

Opinion: Hospital financing in black and white

By Gracie Himmelstein and Joniqua Ceasar and Kathryn E.W. Himmelstein

Adobe

Hospitals caring for large shares of Black patients were paid $283 less for each day of a hospital stay compared to other hospitals.

Read More

Tuesday, September 20, 2022

STAT

Facebook   Twitter   YouTube   Instagram

1 Exchange Pl, Suite 201, Boston, MA 02109
©2022, All Rights Reserved.
I no longer wish to receive STAT emails
Update Email Preferences | Contact Us | View In Browser

No comments